Amyloid-Beta Solubility in the Treatment of Alzheimer's Disease
- PMID: 29365295
- DOI: 10.1056/NEJMe1714638
Amyloid-Beta Solubility in the Treatment of Alzheimer's Disease
Comment on
-
Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease.N Engl J Med. 2018 Jan 25;378(4):321-330. doi: 10.1056/NEJMoa1705971. N Engl J Med. 2018. PMID: 29365294 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical